LAES Exercise Disclosure
Enguent Jean-pierre · SEC Form 4 · Filed Oct 7, 2026
Exercise
Calculated transaction value
$0
Enguent Jean-pierre Vice President, R&dss
LAES
Transaction date
Oct 5, 2026
Public filing date
Oct 7, 2026
Filing lag
Filed 2 days later
LAES daily price context
Close on/before transaction
$2.41
Oct 5, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option Plan (right to buy) on Ordinary Shares
- Quantity / price
- 35,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002114888-26-000017
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$86.29K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Sealsq Corp LAES | Sale | Oct 6, 2026 | $85.94K |
| Sealsq Corp LAES | Exercise | Oct 5, 2026 | $350 |
| Sealsq Corp LAES Current | Exercise | Oct 5, 2026 | $0 |
| Sealsq Corp LAES | Award | Oct 5, 2026 | $0 |